Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultrastruct Pathol ; 39(5): 340-50, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26214044

RESUMO

Mitochondrial morphology was studied in cultivated myoblasts obtained from patients with mitochondrial disorders, including CPEO, MELAS and TMEM70 deficiency. Mitochondrial networks and ultrastructure were visualized by fluorescence microscopy and transmission electron microscopy, respectively. A heterogeneous picture of abnormally sized and shaped mitochondria with fragmentation, shortening, and aberrant cristae, lower density of mitochondria and an increased number of "megamitochondria" were found in patient myoblasts. Morphometric Fiji analyses revealed different mitochondrial network properties in myoblasts from patients and controls. The small number of cultivated myoblasts required for semiautomatic morphometric image analysis makes this tool useful for estimating mitochondrial disturbances in patients with mitochondrial disorders.


Assuntos
Mitocôndrias/ultraestrutura , Doenças Mitocondriais/patologia , Mioblastos/ultraestrutura , Criança , Feminino , Humanos , Lactente , Masculino , Microscopia Eletrônica de Transmissão , Microscopia de Fluorescência
2.
Cesk Fysiol ; 64(2): 84-9, 2015.
Artigo em Tcheco | MEDLINE | ID: mdl-26852526

RESUMO

Mitochondria are organelles producing macroergic compounds in basically all eukaryotic cells except mature erythrocytes. Mitochondria play an important role even in mammalian spermatozoa, in which mitochondrial ATP biosynthesis covers energetic demands connected with sperm movement (motility), maturation (including capacitation) and oocyte fertilisation. Mitochondrial localization and the existence of some specific mitochondrial-protein isoforms point at its indispensable role in fertility maintenance. Mitochondrial disorders are often manifested in tissues with high-energy demands (myopathy, neuropathy, cardiomyopathy), but mitochondrial dysfunction can be often detected also in other peripheral tissues and cells like spermatozoa. The main goal of this minireview is to summarize the most important findings about mitochondria producing cellular ATP supply and to present spermatozoa as a suitable and valuable biological material, which might be, despite of its uniqueness, a very useful material in clinical diagnostics of certain disorders including mitochondrial or neurodegenerative disorders.


Assuntos
Mitocôndrias/metabolismo , Doenças Mitocondriais/fisiopatologia , Espermatozoides/fisiologia , Animais , Masculino , Mamíferos , Motilidade dos Espermatozoides
3.
Mol Genet Metab ; 101(2-3): 286-8, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20674424

RESUMO

Succinylpurines accumulate in the body fluids of patients with adenylosuccinate lyase (ADSL) deficiency but their source in the cerebrospinal fluid remains obscure. Study based on the incorporation of 13C-stable isotope-labeled glycine into cultured oligodendroglia from ADSL-deficient patient and the measurement of labeled products by LC/MS/MS showed total intracellular concentrations of succinylpurines from 45 to 99µmol/l and so these results suggest that these cells can be the source of the compounds in vivo.


Assuntos
Monofosfato de Adenosina/análogos & derivados , Adenilossuccinato Liase/deficiência , Aminoimidazol Carboxamida/análogos & derivados , Oligodendroglia/metabolismo , Ribonucleosídeos/biossíntese , Monofosfato de Adenosina/biossíntese , Evolução Fatal , Humanos , Recém-Nascido , Masculino
4.
Cardiovasc Res ; 31(4): 568-76, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8689648

RESUMO

OBJECTIVE: The aim was to study the effect of the AT1 receptor antagonist losartan on hemodynamic and morphometric changes following experimental infarction. METHODS: Experimental infarction was produced in adult male rats by ligating the coronary artery. Treatment with losartan was compared to untreated controls, in rats with experimental infarction and sham-operated animals. RESULTS: Infarcted hearts were characterized by significant decreases in left ventricular developed pressure, as well as positive and negative (dP/dt)max, whereas left ventricular end-diastolic pressure (LVEDP), relaxation constant tau and right ventricular systolic pressure (RVSP) significantly increased. Treatment with losartan decreased the LVEDP, the relaxation constant tau and RVSP in the infarcted hearts. Right ventricular weight significantly increased in rats with infarction; this was attenuated by losartan. Infarct size was not significantly influenced by losartan treatment. Morphometric data revealed decreased capillary supply in infarcted hearts, especially in regions close to infarction; the decrease was less pronounced after losartan treatment. Capillary density in near infarct region decreased from 2826/mm2 to 1471/mm2 in untreated animals but in the treated animals it decreased from 2982/mm2 to only 2037/mm2. Simultaneous significant decrease in myocyte-to-capillary ratio in treated animals compared to untreated rats (0.87 to 0.67) seems to indicate formation of new capillary channels after losartan treatment. LVEDP was dependent on the size of infarction in untreated but not in treated animals. A close correlation between LVEDP and capillary density was found. CONCLUSIONS: Decreased ventricular contractility, prolonged relaxation and decreased coronary capillary density in rat experimental cardiac infarction confirm and amplify previous reports dealing with this experimental model. Moreover, we have found evidence of improved hemodynamics and coronary angiogenesis after losartan treatment.


Assuntos
Angiotensina I/antagonistas & inibidores , Antagonistas de Receptores de Angiotensina , Compostos de Bifenilo/uso terapêutico , Coração/efeitos dos fármacos , Imidazóis/uso terapêutico , Infarto do Miocárdio/tratamento farmacológico , Tetrazóis/uso terapêutico , Animais , Pressão Sanguínea/efeitos dos fármacos , Capilares , Vasos Coronários/efeitos dos fármacos , Losartan , Masculino , Neovascularização Fisiológica/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Pressão Ventricular/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA